Clinical Trial Update: 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE [Phase 4]

View source ↗

Summary

Phase 4 trial comparing 3 months versus 6 months of anticoagulation in patients with deep vein thrombosis and/or pulmonary embolism; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism

Snippet

Sponsor: British Thoracic Society | Conditions: Deep Vein Thrombosis, Pulmonary Embolism | Phase 4 | Status: COMPLETED